Wednesday, 14 Nov 2018

You are here

Physician Conflicts Overlooked by Physicians

An analysis of Centers for Medicare & Medicaid Services Open Payments Database (OPD) shows a high level of inconsistency for physician self-declared conflicts of interest amongst physicians receiving the highest industry payments. These findings were unrelated to academic rank or productivity and industrial payments.

They analyzed 100 physicians receiving the highest compensation (per CMS OPD) from 10 large surgical and medical device manufacturers. Overall COI was declared by the only 37% of authors from relevant 2016 publications. 

These 100 physicians were paid a total of $12,446,969, with a median payment of $95,993. Half were from academic institutions. In 2016, these authors published 412 articles with mean (SD) of 4 (6) publications (range, 0-25). Half (54.6%) were relevant to the general payments received by the authors, but only in 37% (84 of the 225) of relevant publications was the potential COI declared by the authors.

Gaps in reporting conflicts appear to be compounded by authors who perceive no conflicts. 

Disclosures: 
The author has no conflicts of interest to disclose related to this subject

Add new comment

More Like This

MMWR: Death by Firearms

The CDC's Morbidity and Mortality Weekly Report (MMWR) reports that during 2015–2016 there was a total of 27,394 firearm homicides and 44,955 firearm suicides among US residents, with 12% and 5% of events occuring in children 10–19 years.

RheumNow Weekly Podcast – 3 Wiseguy Rheumatologists (11.9.18)

Dr Jack Cush reviews the News and Journal reports from the past week on RheumNow.com.  Be sure to check out our upcoming meeting in March 2019 - RheumNow Live.

E/M Guidelines: Right Road, Wrong Direction

Last July, the Centers for Medicare & Medicaid Services (CMS) proposed new E/M guidelines for office visits with physicians. It issued the final guidelines on November 1, with a few tweaks. Implementation was delayed until 2021 (from 2019), possibly due to overwhelming opposition from physicians.

RheumNow Week in Review – The Heart Attack Report (11.2.18)

Dr Jack Cush reviews the news and journal reports from the past week on RheumNow.com.

'These Results Are Astonishing': What We Heard at ACR 2018

"If radiation was a drug that could improve survival in the metastatic setting like that it would be millions and millions of dollars." -- James B. Yu, of Yale Cancer Center, discussing aggressive use of stereotactic body radiation therapy in oligometastatic cancer.

*******************************************************